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Tumor necrosis factor alpha (TNF-α) expression amplifies to excess amounts in 
several disorders such as rheumatoid arthritis and psoriasis. Although, Anti-TNF 
biologics have revolutionized the treatment of these autoimmune diseases, formation 
of anti-drug antibodies (ADA) has dramatically affected their use. The next 
generation antibodies (e.g. Fab, scFv) have not only reduced resulted 
immunogenicity, but also proved several benefits including better tumor penetration 
and more rapid blood clearance.This study highlights the use of phage display for 
identification of human single chain fragment antibody against disulfide-bonded 
TNF-α using phage display technology.  
Methods and Results: 
Using affinity selection procedures in this study, a scFv antibody clone was isolated 
from naïve Tomlinson I phage display library that specifically recognizes and binds 
to TNF-α. The TNF-α recombinant protein was expressed in genetically engineered 
Escherichia coli SHuffle
®
 T7 Express, for the first time, which is able to express 
disulfide-bonded recombinant proteins into their correctly folded states. 
Conclusions: 
ELISA-based affinity characterization results indicated that the isolated novel 29.2 
kDa scFv binds TNF-α with suitable affinity. In silico homology modeling study 
using ‘ModWeb’ as well as molecular docking study using Hex program confirmed 
the scFv and TNF-α interactions with a scFv-TNF- α binding energy of around -593 
kj/mol which is well in agreement with our ELSIA results. The cloned scFv antibody 
may potentially be useful for research and therapeutic applications in the future. 
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